Bio-Pharmaceutical Sciences and Education

Specialisation of: Bio-Pharmaceutical Sciences
Degree: Master of Science in Bio-Pharmaceutical Sciences
Mode of Study: Full-time
Duration: 2 years
Start date: Flexible
Language of instruction: English and Dutch
Location: Leiden
Croho/isat code: 60207
Share |

The Master’s specialisation in Bio-Pharmaceutical Sciences and Education comprises a one-year pharmaceutical component (taught in English) and a one-year teacher-training programme (taught in Dutch).

Programme

The research component of the specialisation consists of a research project in one of the research groups at the Center for Bio-Pharmaceutical Sciences, including a master’s thesis and an oral presentation, and courses to be selected in consultation with an adviser.
The education part of the programme (60 EC) is taught in Dutch. It is offered by the Leiden University Graduate School of Teaching (ICLON), and consists of courses in Educational Theory, Supervision of Professional Development and Teaching Methodology, a specialisation course and teaching practice.
For students attending the Education specialisation it is strongly recommended that the BSc programme has included the 10 EC course Learning, Presentation and Communication, offered by the Leiden University Graduate School of Teaching (ICLON), or an equivalent course.

e-Prospectus Bio-Pharmaceutical Sciences and Education

Photo BFW 2

Prof. Meindert Danhof

“LACDR’s research is focused on the development of new strategies for the discovery and development of new medicines.”

“The MSC in Bio-Pharmaceutical Sciences focuses on the discovery and development of new medicines, and as such is unique in the world. The study is directly linked to the research programme of the Leiden Amsterdam Center for Drug Research (LACDR), which is regarded worldwide as one of the opinion-leaders in the field of innovative drug research.

The discovery and development of new medicines is important because for many serious diseases there are still no effective treatments available. The development of new medicines still constitutes a great challenge. At the moment the likelihood of producing an effective new drug is quite limited: of all the medicines tested on humans, only 8% actually reach the patient.

Moreover, it takes a long time to develop such medicines: 10 – 15 years on average. This means that the costs of developing a new medicine can be as much as Euro 1 billion. LACDR’s research is focused on the development of new strategies for the discovery and development of new medicines.

A further distinctive aspect of this master’s programme is the intensive co-operation with the international pharmaceutical industry. We also participate in the Top Institute Pharma (TI Pharma). We offer our students many opportunities to gain experience through work placements in the research departments of pharmaceutical companies.”